World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30585
World Ranking
11320
National Ranking
5810

G. David Roodman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where G. David Roodman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 357 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

G. David Roodman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where G. David Roodman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

G. David Roodman is affiliated with Indiana University in the United States. Their research spans the field of Medicine, with a primary focus on Oncology and Hematology, as well as related areas such as Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Genetics.

The scientist's main research topics encompass:

  • Multiple Myeloma Research and Treatments
  • Bone health and treatments
  • Peptidase Inhibition and Analysis
  • CAR-T cell therapy research
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Sphingolipid Metabolism and Signaling
  • Ubiquitin and proteasome pathways

G. David Roodman has contributed to several scientific papers, including:

  • Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction (2022), published in Neoplasia
  • GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival (2022), published in Cancers
  • Mapping the High-Risk Multiple Myeloma Cell Surface Proteome Identifies T-Cell Inhibitory Receptors for Immune Targeting (2021), published in Blood
  • A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma (2024), published in Haematologica
  • Osteocytes and Paget's Disease of Bone (2024), published in Current Osteoporosis Reports

The frequent co-authors in their works include Jesús Delgado-Calle, Hayley M. Sabol, Cody Ashby, Noriyoshi Kurihara, and Teresita Bellido.

The main venues for their publications feature journals such as Neoplasia, Cancers, Haematologica, Blood, and Current Osteoporosis Reports.

G. David Roodman has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2012 and is a member of the Association of American Physicians.

Best Publications

  • Mechanisms of bone metastasis.

    G. David Roodman

  • Primer on the metabolic bone diseases and disorders of mineral metabolism

    John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston

  • Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

    N Takahashi;H Yamana;S Yoshiki;G D Roodman

  • Cell biology of the osteoclast.

    G.David Roodman

  • Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

    Yazan Alsayed;Hai Ngo;Judith Runnels;Xavier Leleu

  • Pathogenesis of myeloma bone disease

    G. David Roodman;G. David Roodman

  • Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma

    Sun Jin Choi;Jose C. Cruz;Fiona Craig;Hoyeon Chung

  • Biology of osteoclast activation in cancer.

    G. David Roodman

  • International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease

    Evangelos Terpos;Gareth Morgan;Meletios Athanasios Dimopoulos;Matthew T. Drake

  • Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

    Noopur Raje;Evangelos Terpos;Wolfgang Willenbacher;Kazuyuki Shimizu

  • Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures

    C Chenu;J Pfeilschifter;G R Mundy;G D Roodman

  • Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement

    Meletios A. Dimopoulos;Jens Hillengass;Saad Usmani;Elena Zamagni

  • Paget disease of bone

    G. David Roodman;Jolene J. Windle

  • Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.

    Nicola Giuliani;Nicola Giuliani;Vittorio Rizzoli;Vittorio Rizzoli;G. David Roodman;G. David Roodman

  • Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand

    Je-Ho Han;Sun Jin Choi;Noriyoshi Kurihara;Masanori Koide

  • 1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow.

    G D Roodman;K J Ibbotson;B R MacDonald;T J Kuehl

  • Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.

    Jussi M. Halleen;Seija Räisänen;Jari J. Salo;Sakamuri V. Reddy

  • Excess TGF-β mediates muscle weakness associated with bone metastases in mice

    David L Waning;Khalid S Mohammad;Steven Reiken;Wenjun Xie

  • Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

    Sun Jin Choi;Yasuo Oba;Yair Gazitt;Melissa Alsina

  • Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

    J de la Mata;H L Uy;T A Guise;B Story

Frequent Co-Authors

Irene M. Ghobrial
Irene M. Ghobrial Harvard University
Teresita Bellido
Teresita Bellido University of Arkansas for Medical Sciences
Noopur Raje
Noopur Raje Harvard University
Guozhi Xiao
Guozhi Xiao Southern University of Science and Technology
David W. Dempster
David W. Dempster Columbia University
Evangelos Terpos
Evangelos Terpos National and Kapodistrian University of Athens
Michael P. Whyte
Michael P. Whyte Washington University in St. Louis
Allan Lipton
Allan Lipton Penn State Milton S. Hershey Medical Center
Matthew R. Smith
Matthew R. Smith Harvard University
Robin J. Leach
Robin J. Leach The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternatives or complementary paths to traditional MD programs, a range of online healthcare degrees are now more accessible than ever. Flexible learning options can help you start or advance your medical career, often at your own pace and from anywhere.

For those interested in doctor-level practice without extensive residency, a dnp program without clinical hours offers a pathway to advanced nursing leadership roles, focusing primarily on administrative and research skills.

Entry-level roles, such as Licensed Practical Nurse, are now achievable through online lpn programs, which provide foundational medical training and can often be completed quickly.

For those aiming to specialize in mental health, students can choose from the fastest pmhnp program options to become advanced practice psychiatric nurse practitioners.

Alternatively, leadership and administrative careers in healthcare are opened by earning a health administration degree online, preparing graduates for management roles without hands-on clinical requirements.

Best Scientists Citing G. David Roodman

Trending Scientists

Recently Published Articles